BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 10, 2007
View Archived Issues
Novel recombinant poxvirus vaccine candidates immunogenic against HIV antigens in mice
Read More
HuMAb 17C7: a new monoclonal antibody against rabies
Read More
Novel anticancer compounds reported in recent patent literature
Read More
Tasquinimod enhances response to androgen ablation in prostate cancer models
Read More
GlaxoSmithKline reports on novel compounds with in vitro activity against human papilloma virus
Read More
Recent Tokai University and Sankyo patent covers new therapeutic agents for renal disorders
Read More
Novel VLA-1 antagonists presented at the recent ACS meeting
Read More
New treatment options for gastrointestinal disorders disclosed in recent patent literature
Read More
Enrollment progresses in phase III study of Rencarex
Read More
Vicinium studied in phase II for locally persistent noninvasive bladder cancer
Read More
SuperGen completes sale of remaining Nipent rights
Read More
Lilly withdraws E.U. marketing authorization application for Arxxant
Read More
Wyeth brings to 100% its ownership stake in Wyeth K.K. Japan
Read More
Surface Logix closes second tranche of Series D financing
Read More
Acomplia approved in Switzerland
Read More
Taxus Express2 paclitaxel-eluting coronary stent system approved in Japan
Read More
Proellex improves symptoms associated with uterine fibroids
Read More
Final median survival data from phase II GVAX prostate cancer study
Read More
Glycopyrrolate begins pivotal safety study in pediatric drooling
Read More
LX-201 begins pivotal trials
Read More
Femathina studied for endometrial thinning in new phase II trial
Read More
MB-07803 begins proof-of-concept study in type 2 diabetes
Read More
Roche to acquire Bioveris
Read More
Basiliximab studied for ulcerative colitis in phase IIb trial
Read More
Ceflatonin studied in new phase II/III study in CML
Read More
FDA approves new coated Niaspan tablet
Read More
